Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: NanoViricides Inc. NNVC

MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present Breakthrough Virotherapy Platform at AACR 2025

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, announced its abstract, “Development of a Systemic Enveloped Virotherapy for Targeting All Metastatic Sites,” has been accepted for presentation at the American Association for Cancer Research … Continue reading

Posted in NanoViricides Inc. NNVC | Leave a comment